Interventions for improving outcomes in patients with multimorbidity in primary care and community settings

SM Smith, E Wallace, T O'Dowd… - Cochrane Database of …, 2016 - cochranelibrary.com
Background Many people with chronic disease have more than one chronic condition, which
is referred to as multimorbidity. The term comorbidity is also used but this is now taken to …

[HTML][HTML] A review of therapeutic uses of mirtazapine in psychiatric and medical conditions

A Alam, Z Voronovich, JA Carley - The primary care companion for …, 2013 - psychiatrist.com
Objective: To review the literature examining the use of mirtazapine with an emphasis on its
therapeutic benefits for psychiatric patients with comorbid medical conditions. Data Sources …

Repetitive transcranial magnetic stimulation increases serum brain-derived neurotrophic factor and decreases interleukin-1β and tumor necrosis factor-α in elderly …

X Zhao, Y Li, Q Tian, B Zhu… - Journal of International …, 2019 - journals.sagepub.com
Objective To investigate the effects of repetitive transcranial magnetic stimulation (rTMS) on
serum levels of brain-derived neurotrophic factor (BDNF), interleukin (IL)-1β, and tumor …

Reported side effects, weight and blood pressure, after repeated sessions of transcranial photobiomodulation

P Cassano, MA Caldieraro, R Norton… - … , and laser surgery, 2019 - liebertpub.com
Background: Transcranial photobiomodulation (t-PBM) consists in the delivery of near-
infrared light (NIR) to the scalp, directed to cortical areas of the brain. NIR t-PBM recently …

The onset and accumulation of physical multimorbidity in severe and common mental disorders

IŠ Filipcic, Ž Bajic, I Filipcic - Current opinion in psychiatry, 2020 - journals.lww.com
To address physical health inequalities among people with mental disorders compared with
the general population, we must focus on the physical health from the very first point of …

Antidepressant treatment outcomes in patients with and without comorbid physical or psychiatric disorders: a systematic review and meta-analysis

HK Kim, DM Blumberger, PB Fitzgerald… - Journal of Affective …, 2021 - Elsevier
Background Many patients with major depressive disorder (MDD) experience substantial
impairment despite the availability of efficacious treatments. We performed a systematic …

General predictors and moderators of depression remission: a VAST-D report

S Zisook, GR Johnson, I Tal, P Hicks… - American Journal of …, 2019 - Am Psychiatric Assoc
Objective: Almost two-thirds of patients with major depressive disorder do not achieve
remission with initial treatments. Thus, identifying and providing effective, feasible, and safe …

Pediatric inflammatory bowel disease and depression: treatment implications

D Keethy, C Mrakotsky, E Szigethy - Current Opinion in Pediatrics, 2014 - journals.lww.com
Pediatric inflammatory bowel disease and depression: treatme... : Current Opinion in
Pediatrics Pediatric inflammatory bowel disease and depression: treatment implications …

[HTML][HTML] Tolerability and safety of transcranial photobiomodulation for mood and anxiety disorders

P Cassano, R Norton, MA Caldieraro, F Vahedifard… - Photonics, 2022 - mdpi.com
Introduction: Mood and anxiety disorders are a prevalent and significant leading cause of
years lived with a disability worldwide. Existing antidepressants drugs are only partially …

The association between antidepressant use and glycemic control in the Southern Community Cohort Study (SCCS)

JR Kammer, AS Hosler, E Leckman-Westin… - Journal of Diabetes and …, 2016 - Elsevier
Introduction Among people with diabetes, comorbid depression has been associated with
suboptimal health outcomes. However, the independent impact of antidepressant use on …